publications
2024
-
Comparative characterization of two monoclonal antibodies targeting canine PD-1Frontiers in Immunology, 2024
-
Multi-Omic Analysis of Esophageal Adenocarcinoma Uncovers Candidate Therapeutic Targets and Cancer-Selective Posttranscriptional RegulationMolecular & Cellular Proteomics, 2024
-
Barking Up the Right Tree: Immune Checkpoint Signatures of Human and Dog CancersbioRxiv, 2024
2022
-
Design, synthesis and biological evaluation of PD-1 derived peptides as inhibitors of PD-1/PD-L1 complex formation for cancer therapyBioorganic Chemistry, 2022
-
Development of monoclonal antibodies targeting canine PD-L1 and PD-1 and their clinical relevance in canine apocrine gland anal sac adenocarcinomaCancers, 2022
2021
-
Hydrogen deuterium exchange mass spectrometry identifies the dominant paratope in CD20 antigen binding to the NCD1. 2 monoclonal antibodyBiochemical Journal, 2021
2020
-
Hyperprogression under immune checkpoint-based immunotherapy—current understanding, the role of pd-1/pd-l1 tumour-intrinsic signalling, future directions and a potential large animal modelCancers, 2020
2019
-
Analysis of venom sac constituents from the solitary, aculeate wasp Cerceris rybyensisToxicon, 2019